JPMorgan cuts Abbott India target price; pharma stock downgrade
JPMorgan cuts Abbott India target price in bearish call on pharma stock. The downgrade reflects concerns over valuation and growth prospects for the pharmaceutical company. This broker call may trigger selling pressure among retail and institutional investors holding the stock. Monitor support levels for potential entry opportunities.
📊 STOCKS: $ABBOTINDIA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #broker_downgrade
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.